The Effect of Donepezil in Radiotherapy-related Cognitive Impairment.

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2019
Purpose: This randomized, double-blind, placebo-controlled clinical trial aims to evaluate the therapeutic effects of donepezil in radiotherapy-related cognitive impairment. Further study details as provided by Sun Yat-sen Memorial Hospital, Sun Yat-sen University / Yameitang. Primary outcome measure: cognitive improvement, which is determined by the difference value of ADAS-cog score before and after the treatment of donepezil.
Epistemonikos ID: cf83de67a24f1c29c0513ea369e6927e650d246c
First added on: May 22, 2024